Leaders inside the Drug Repositioning and Repurposing subject to meet for sixth Annual Drug Repositioning convention in Chicago in June 2017
benefit Healthcare India 2017, Oct. 12 - 14, 2017 at Bengaluru, India
Arrowhead Publishers is comfortable to announce that the sixth Annual Drug Repositioning, Repurposing and Rescue convention will possible be taking place June 27-28, 2017 in Chicago, IL. This event will current a platform for a quantity of stakeholders furthering drug development by a quantity of collaborations, collectively with affected person advocacy efforts and enterprise/educational/authorities cooperation. For extra information, go to: www.drugrepositioningconference.com/brochure.
This 12 months's convention will possible be centered on using repurposing to get hold of and develop new therapies for unusual illnesses. a quantity of key themes at this event will embody:
- affected person Advocacy Efforts: Emphasis on and engagement with affected person advocacy teams, who're investigating in drug repositioning efforts to an unprecedented diploma
- New Partnerships: The convention will discover how new partnerships between numerous teams, collectively with authorities, enterprise and academia are teaming as a lot as advance repurposing efforts
- industrial Case research: Leaders in drug repositioning will discuss about their successes, failures and the best method forward
- Collaborative efforts: authorities/educational/enterprise collaborations will possible be explored and highlighted in an effort to get hold of out how disparate teams can obtain success
- Systematic Repositioning and information Analytics: Repurposing is not primarily based on serendipity as more and more extra firms are designing devices to streamline and enhance the percentages of success
Featured audio system embody:
- Ronald Alfa, MD, Ph.D., vp, Discovery and Product, Recursion prescribed medicine
- Bobbie Ann Austin, Ph.D., Program Officer, Drug development Partnership functions, nationwide coronary heart for Advancing Translational Sciences (NCATS), office of the Director, nationwide Institutes of well being
- Pieter Dylst, Senior supervisor Market entry and worth Added Medicines, Medicines for Europe
- Laura Kleiman, Ph.D., Scientific evaluation Director, cBio coronary heart, Dana-Farber most cancers Institute
- Daphna Laifenfeld, Ph.D., Sr. Director, personalised & Predictive medicine, Teva Pharmaceutical Industries
- Kevin Pan, Ph.D., Chief authorities Officer, Asieris prescribed medicine
- Aris Persidis, Ph.D., President, Biovista
- Michael Pollastri, Ph.D., affiliate Professor & Chair, Northeastern college, faculty of Science
- Vidula Sukhatme, Founder and CEO, world Cures
Please go to www.drugrepositioningconference.com/audio system for the complete talking faculty.
For extra information, please contact:
John Waslif: Managing Director, Arrowhead Publishers 866-945-0263 ext seven-hundred, john.waslif@arrowheadpublishers.com
Rachel Donlon: advertising affiliate, Arrowhead Publishers 866-945-0263 ext 701, rachel.donlon@arrowheadpublishers.com
![]()
